HANGZHOU, China, Jan. 20, 2020 /PRNewswire/ — The leading transcatheter heart valve medical device player in China – Venus Medtech (Hangzhou) Inc. (“Venus Medtech” or the “Company“, stock code: 2500.HK), today is pleased to announce the appointment of two new cardiovascular experts to its advisory team. Dr. Scott […]
Tag: Venus Medtech
Venus Medtech Raised $308M in HK IPO
written by Eudora Wang, Deal street Asia Chinese Heart Valve Device Maker Venus Medtech Nabs $308m in HK IPO December 10, 2019 – Venus Medtech, a Chinese company that produces heart valve replacement devices, has raised HK$2.41 billion ($308 million) […]
Venus Medtech Completes Merger with Keystone Heart, LTD
HANGZHOU, China and CAESAREA, Israel and TAMPA, Fla., Dec. 26, 2018 /PRNewswire/ — Venus Medtech (Hangzhou) Inc., the preeminent Chinese transcatheter heart valve company, today announced it has closed its Merger with Keystone Heart Ltd., a privately-held medical device company and makers of TriGUARD 3™. The Merger provides Venus Medtech […]
Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD
HANGZHOU, China, CAESAREA, Israel, TAMPA, Florida — September 25, 2018— Venus Medtech (Hangzhou) Inc., the preeminent Chinese transcatheter heart valve company, today announced it has signed an agreement to acquire Keystone Heart Ltd., a privately-held medical device company and makers […]
Venus Medtech Launches Global Advisory Board to Target for International Market
SAN DIEGO, Sept. 24, 2018 /PRNewswire/ — Venus Medtech (Hangzhou) Inc., a Chinese medical device company specializing in transcatheter valve replacement therapy, has retained four world-renowned experts specialized in interventional cardiovascular to form a Global Advisory Board. The Board members will contribute their insights […]
Venus Medtech Enters North American Market
HANGZHOU, China and VANCOUVER, Canada, June 14, 2018 /PRNewswire/ — On June 12, 2018, St Paul ‘s Hospital in Vancouver, Canada successfully completed two cases of VenusP-Valve self-expanding pulmonary valve implantation. This is the first appearance of Venus Medtech’s transcatheter valve products in North America. The pace of internationalization continues […]
First Successful Clinical Implantation of Transcatheter Pulmonary Valve VenusP-Valve was Successfully Completed in Brazil
SAO PAULO, Dec. 22, 2017 /PRNewswire/ — On December 19, 2017, local time, 4 clinical implantations of transcatheter pulmonary valve VenusP-Valve were successfully completed in Brazil by Professor Carlos Pedra from Dante Pazzanese Institute of Cardiovascular Technology in Sao Paulo, Brazil. After Chile and Argentina, Brazil becomes the third Latin American country to apply […]